John A. Tine

1.1k total citations
21 papers, 890 citations indexed

About

John A. Tine is a scholar working on Molecular Biology, Immunology and Virology. According to data from OpenAlex, John A. Tine has authored 21 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Immunology and 5 papers in Virology. Recurrent topics in John A. Tine's work include Immunotherapy and Immune Responses (8 papers), vaccines and immunoinformatics approaches (5 papers) and HIV Research and Treatment (4 papers). John A. Tine is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), vaccines and immunoinformatics approaches (5 papers) and HIV Research and Treatment (4 papers). John A. Tine collaborates with scholars based in United States, Netherlands and China. John A. Tine's co-authors include Stephen L. Hoffman, Richard C. Hedstrom, Martha Sedegah, Peter Hobart, Walter R. Weiss, Manjit Kaur, Trevor R. Jones, Sanjai Kumar, Kalpana Gowda and William O. Rogers and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Annals of the New York Academy of Sciences.

In The Last Decade

John A. Tine

21 papers receiving 867 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John A. Tine United States 14 439 366 263 181 144 21 890
Claire Hutchings United Kingdom 17 361 0.8× 271 0.7× 261 1.0× 100 0.6× 262 1.8× 28 905
Jean‐Hervé Colle France 17 502 1.1× 144 0.4× 151 0.6× 283 1.6× 227 1.6× 45 864
Joo-Sung Yang South Korea 16 400 0.9× 335 0.9× 119 0.5× 166 0.9× 143 1.0× 19 910
Kristina K. Peachman United States 22 577 1.3× 453 1.2× 147 0.6× 292 1.6× 184 1.3× 45 1.2k
Anda I. Meierovics United States 10 520 1.2× 453 1.2× 91 0.3× 100 0.6× 172 1.2× 12 1.0k
Kelly M. Rausch United States 18 371 0.8× 481 1.3× 437 1.7× 87 0.5× 115 0.8× 27 1.0k
M Sedegah United States 7 509 1.2× 376 1.0× 658 2.5× 133 0.7× 184 1.3× 9 1.1k
Shigeto Yoshida Japan 25 461 1.1× 566 1.5× 616 2.3× 66 0.4× 277 1.9× 69 1.5k
Thera Mulvania United States 7 661 1.5× 145 0.4× 63 0.2× 142 0.8× 132 0.9× 10 965
M F Leef United States 14 263 0.6× 229 0.6× 302 1.1× 66 0.4× 287 2.0× 22 817

Countries citing papers authored by John A. Tine

Since Specialization
Citations

This map shows the geographic impact of John A. Tine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Tine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Tine more than expected).

Fields of papers citing papers by John A. Tine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Tine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Tine. The network helps show where John A. Tine may publish in the future.

Co-authorship network of co-authors of John A. Tine

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Tine. A scholar is included among the top collaborators of John A. Tine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Tine. John A. Tine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Preston, Karen E. & John A. Tine. (2017). Acquisition of a second multi-drug resistance-encoding element by IncM1 plasmid pACM130 abolished conjugative transfer. Plasmid. 92. 26–29. 1 indexed citations
3.
Preston, Karen E., et al.. (2014). The complete nucleotide sequence of the multi-drug resistance-encoding IncL/M plasmid pACM1. Plasmid. 76. 54–65. 12 indexed citations
4.
Felker, Péter, et al.. (2010). PROGRESO EN LA IDENTIFICACIÓN DEL AGENTE CAUSAL DE "ENGROSAMIENTO DEL CLADODIO O MACHO". 1 indexed citations
5.
Avasarala, Jagannadha, Sridar V. Chittur, Ajish George, & John A. Tine. (2008). Microarray analysis in B cells among siblings with/without MS - role for transcription factor TCF2. BMC Medical Genomics. 1(1). 2–2. 12 indexed citations
6.
Eifert, Cheryl, Niquiche Sangster‐Guity, Liming Yu, et al.. (2006). Global gene expression profiles associated with retinoic acid‐induced differentiation of embryonal carcinoma cells. Molecular Reproduction and Development. 73(7). 796–824. 30 indexed citations
7.
Li, Li, Todd D. Porter, Neil S. Jensen, et al.. (2006). NEW CYTOCHROME P450 2D6*56 ALLELE IDENTIFIED BY GENOTYPE/PHENOTYPE ANALYSIS OF CRYOPRESERVED HUMAN HEPATOCYTES. Drug Metabolism and Disposition. 34(8). 1411–1416. 12 indexed citations
8.
Tine, John A., Hüseyin Firat, Anne F. Payne, et al.. (2004). Enhanced multiepitope-based vaccines elicit CD8+ cytotoxic T cells against both immunodominant and cryptic epitopes. Vaccine. 23(8). 1085–1091. 22 indexed citations
9.
10.
Rogers, William O., Walter R. Weiss, Anita Kumar, et al.. (2002). Protection of Rhesus Macaques against LethalPlasmodium knowlesiMalaria by a Heterologous DNA Priming and Poxvirus Boosting Immunization Regimen. Infection and Immunity. 70(8). 4329–4335. 57 indexed citations
11.
Kumar, Anita, Walter R. Weiss, John A. Tine, Stephen L. Hoffman, & William O. Rogers. (2001). ELISPOT assay for detection of peptide specific Interferon-γ secreting cells in rhesus macaques. Journal of Immunological Methods. 247(1-2). 49–60. 38 indexed citations
12.
Rogers, William O., J. Kevin Baird, Anita Kumar, et al.. (2001). Multistage Multiantigen Heterologous Prime Boost Vaccine forPlasmodium knowlesiMalaria Provides Partial Protection in Rhesus Macaques. Infection and Immunity. 69(9). 5565–5572. 65 indexed citations
13.
Sutmuller, Roger P.M., Leonie M. van Duivenvoorde, John A. Tine, et al.. (2000). Adoptive T Cell Immunotherapy of Human Uveal Melanoma Targeting gp100. The Journal of Immunology. 165(12). 7308–7315. 28 indexed citations
14.
Sedegah, Martha, Walter R. Weiss, John B. Sacci, et al.. (2000). Improving Protective Immunity Induced by DNA-Based Immunization: Priming with Antigen and GM-CSF-Encoding Plasmid DNA and Boosting with Antigen-Expressing Recombinant Poxvirus. The Journal of Immunology. 164(11). 5905–5912. 106 indexed citations
15.
Hörig, Heidi, David S. Lee, William R. Conkright, et al.. (2000). Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule. Cancer Immunology Immunotherapy. 49(9). 504–514. 165 indexed citations
16.
Wang, Ruobing, Denise L. Doolan, Yupin Charoenvit, et al.. (1998). Simultaneous Induction of Multiple Antigen-Specific Cytotoxic T Lymphocytes in Nonhuman Primates by Immunization with a Mixture of FourPlasmodium falciparumDNA Plasmids. Infection and Immunity. 66(9). 4193–4202. 57 indexed citations
17.
Sedegah, Martha, Trevor R. Jones, Manjit Kaur, et al.. (1998). Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine. Proceedings of the National Academy of Sciences. 95(13). 7648–7653. 189 indexed citations
18.
Perkus, Marion E., Jill Taylor, J. Tartaglia, et al.. (1995). Live Attenuated Vaccinia and Other Poxviruses as Delivery Systems: Public Health Issues. Annals of the New York Academy of Sciences. 754(1). 222–233. 10 indexed citations
19.
Wizel, Benjamin, et al.. (1994). Induction of murine cytotoxic T lymphocytes against Plasmodium falciparum sporozoite surface protein 2. European Journal of Immunology. 24(7). 1487–1495. 17 indexed citations
20.
Tine, John A., et al.. (1990). Genetic polymorphisms ofQ region genes from wild-derived mice: Implications forQ region evolution. Immunogenetics. 31(5-6). 315–325. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claire Hutchings Breakdown of academic impact, for papers by Jean‐Hervé Colle Breakdown of academic impact, for papers by Joo-Sung Yang Breakdown of academic impact, for papers by Kristina K. Peachman Breakdown of academic impact, for papers by Anda I. Meierovics Breakdown of academic impact, for papers by Kelly M. Rausch Breakdown of academic impact, for papers by M Sedegah Breakdown of academic impact, for papers by Shigeto Yoshida Breakdown of academic impact, for papers by Thera Mulvania Breakdown of academic impact, for papers by M F Leef
Rankless by CCL
2026